Showing results (251-260 of 447) with videos related to
Sort By:
Pageof 45
Cardio-Oncology (London, England)|November 11, 2023
Cardiac electrical abnormalities in childhood acute lymphoblastic leukemia survivors: a systematic reviewÉmilie Bertrand, Maxime Caru, Audrey Harvey, et al.Cardio-Oncology (London, England)|September 13, 2023
Cardiometabolic healthcare for men with prostate cancer: an MD Anderson Cancer Center experienceAndrew W Hahn, Whittney Thoman, Efstratios Koutroumpakis, et al.Cardio-Oncology (London, England)|December 10, 2019
Clinical Outcomes after Transcatheter Aortic Valve Replacement in Cancer Survivors Treated with Ionizing RadiationNikhil Agrawal, Sharma Kattel, Sameer Waheed, et al.Cardio-Oncology (London, England)|March 11, 2020
Recurrent heart failure with preserved ejection fraction associated with carfilzomib administration for multiple myelomaEric H Yang, Cynthia Courtney, Vinisha Garg, et al.Cardio-Oncology (London, England)|March 11, 2020
Incidence and outcomes of cancer treatment-related cardiomyopathy among referrals for advanced heart failureRaquel Araujo-Gutierrez, Sergio H Ibarra-Cortez, Jerry D Estep, et al.Cardio-Oncology (London, England)|March 11, 2020
NT-proBNP correlates with LVEF decline in HER2-positive breast cancer patients treated with trastuzumabNathalie I Bouwer, Crista Liesting, Marcel J M Kofflard, et al.Cardio-Oncology (London, England)|March 11, 2020
Electrocardiograms for cardiomyopathy risk stratification in children with anthracycline exposureLajja Desai, Lauren Balmert, Jennifer Reichek, et al.Cardio-Oncology (London, England)|March 11, 2020
Effects of dexrazoxane on doxorubicin-related cardiotoxicity and second malignant neoplasms in children with osteosarcoma: a report from the Children's Oncology GroupLisa M Kopp, Richard B Womer, Cindy L Schwartz, et al.Cardio-Oncology (London, England)|March 11, 2020
Detection of subclinical cardiotoxicity in sarcoma patients receiving continuous doxorubicin infusion or pre-treatment with dexrazoxane before bolus doxorubicinJieli Li, Hui-Ming Chang, Jose Banchs, et al.Cardio-Oncology (London, England)|December 9, 2020
Clinical impact of interruption in adjuvant Trastuzumab therapy in patients with operable HER-2 positive breast cancerSagar Sardesai, Jasmine Sukumar, Mahmoud Kassem, et al.Pageof 45